Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Evaluation of quinupristin/dalfopristin (Synercid) and RPR 106972 stability in susceptibility testing media.

Marshall SA, Kugler KC, Jones RN.

Int J Antimicrob Agents. 2000 Aug;15(4):291-7.

PMID:
10929879
2.
3.
5.

Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study.

Sader HS, Jones RN, Ballow CH, Biedenbach DJ, Cered RF; GSMART Latin America Study Group.

Braz J Infect Dis. 2001 Feb;5(1):21-31.

PMID:
11290311
6.

Activity of quinupristin/dalfopristin and its components against Haemophilus influenzae.

Jorgensen JH, McElmeel ML.

J Antimicrob Chemother. 1997 May;39 Suppl A:69-73.

7.
9.

Antimicrobial activity of quinupristin/dalfopristin, a new injectable streptogramin with a wide Gram-positive spectrum.

Speciale A, La Ferla K, Caccamo F, Nicoletti G.

Int J Antimicrob Agents. 1999 Sep;13(1):21-8.

PMID:
10563401
10.

In vitro activity of an orally administered streptogramin (RPR 106,972) compared to quinupristin/dalfopristin and erythromycin.

Barry AL, Fuchs PC, Brown SD.

Eur J Clin Microbiol Infect Dis. 1997 Feb;16(2):155-8.

PMID:
9105844
11.

Development of provisional disc diffusion breakpoints for testing quinupristin/dalfopristin.

Tenover FC, Baker CN.

J Antimicrob Chemother. 1997 May;39 Suppl A:81-5.

12.

Treatment options for vancomycin-resistant enterococcal infections.

Linden PK.

Drugs. 2002;62(3):425-41. Review.

PMID:
11827558
13.

Activity of quinupristin-dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy.

Pantosti A, D'Ambrosio F, Bordi E, Scotto D'Abusco A, Del Grosso M.

Clin Microbiol Infect. 2001 Sep;7(9):503-6.

16.

Provisional interpretive criteria for quinupristin/dalfopristin susceptibility tests.

Barry AL, Fuchs PC, Brown SD.

J Antimicrob Chemother. 1997 May;39 Suppl A:87-92.

17.

Recent developments in streptogramin research.

Barrière JC, Berthaud N, Beyer D, Dutka-Malen S, Paris JM, Desnottes JF.

Curr Pharm Des. 1998 Apr;4(2):155-80. Review.

PMID:
10197038
18.

Synergic activity of vancomycin-quinupristin/dalfopristin combination against Enterococcus faecium.

Lorian V, Fernandes F.

J Antimicrob Chemother. 1997 May;39 Suppl A:63-6.

20.

In-vitro activity of quinupristin/dalfopristin (Synercid) against isolates of Streptococcus pneumoniae, Staphylococcus aureus and enterococcus spp.

Johnson AP, Warner M, Speller DC.

J Antimicrob Chemother. 1997 Oct;40(4):604-5. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk